Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.

Very late relapse (VLR) occurring>5 years after initial diagnosis is an uncommon event in the management of Hodgkin lymphoma (HL). Limited information regarding risk factors and optimal therapy is available.We reviewed patients treated for HL at Princess Margaret Cancer Centre, Toronto, Ontario Canada between January 01, 1999 to 31 December 31, 2018. Thirty-two (32) patients experienced VLR. Median time to first relapse was 7.2 years. Most patients were treated with CMT both at initial diagnosis and relapse.

Source: Clinical Lymphoma, Myeloma and Leukemia - July 31, 2023 Category: Hematology Authors: Hannah Cherniawsky, Esther Ting, Jasper Zhongyuan Zhang, Wei Xu, Anca Prica, Sita Bhella, Chloe Yang, Robert Kridel, Abirami Vijenthira, Vishal Kukreti, Michael Crump, John Kuruvilla Tags: Original Study Source Type: research